Pharmacokinetics of apixaban
- PMID: 28798509
- PMCID: PMC5478397
- DOI: 10.18773/austprescr.2017.033
Pharmacokinetics of apixaban
Comment on
-
Long-term prescribing of new oral anticoagulants.Aust Prescr. 2016 Dec;39(6):200-204. doi: 10.18773/austprescr.2016.068. Epub 2016 Dec 5. Aust Prescr. 2016. PMID: 27990047 Free PMC article. Review. No abstract available.
References
-
- Chin PK, Doogue MP. Long-term prescribing of new oral anticoagulants. Aust Prescr 2016;39:200-4. https://doi.org/10.18773/austprescr.2016.068 10.18773/austprescr.2016.068 - DOI - PMC - PubMed
-
- Frost C, Boyd RA. The contribution of apixaban renal clearance to total clearance. J Thromb Thrombolysis 2015;40:521-2. https://doi.org/10.1007/s11239-015-1220-8 10.1007/s11239-015-1220-8 - DOI - PMC - PubMed
-
- Hellfritzsch M, Damkier P, Pottegård A, Grønlykke T, Grove EL. Inconsistencies in reporting of renal elimination among NOACs: the case of apixaban. Pharmacoepidemiol Drug Saf 2016;25:346-8. https://doi.org/10.1002/pds.3916 10.1002/pds.3916 - DOI - PubMed
-
- Raghavan N, Frost CE, Yu Z, He K, Zhang H, Humphreys WG, et al. Apixaban metabolism and pharmacokinetics after oral administration to humans. Drug Metab Dispos 2009;37:74-81. https://doi.org/10.1124/dmd.108.023143 10.1124/dmd.108.023143 - DOI - PubMed
-
- Vakkalagadda B, Frost C, Byon W, Boyd RA, Wang J, Zhang D, et al. Effect of rifampin on the pharmacokinetics of apixaban, an oral direct inhibitor of factor Xa. Am J Cardiovasc Drugs 2016;16:119-27. https://doi.org/10.1007/s40256-015-0157-9 10.1007/s40256-015-0157-9 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources